1/4/2022Santhera Enters into Exclusive License Agreement with Sperogenix for V...

1/3/2022Daewoong Submits BTX Product Nabota in China

1/3/2022Hanmi Pharma Out-licenses Retinal Disease Drug to China's AffaMed

1/3/2022Third Former GSK Scientist Pleads Guilty to Stealing Trade Secrets to ...

12/30/2021Sirnaomics Launches IPO on the Main Board of Stock Exchange of Hong K...

12/30/2021Ark Biopharma Enters Into License Deal with Commave for ADHD Drug Azst...

12/30/2021NMPA and Chinese Customs Announce Addition of Zhongshan City's Zhongsh...

12/30/2021NMPA Issues the 14th Five Year Plan for National Drug Safety and Promo...

12/30/2021Financial-related Company News Digest (December 2021)

12/30/2021Recent Executive Moves

12/29/2021Memorial Sloan Kettering and the Chinese Thoracic Oncology Group Discu...

12/29/2021CDE Issues the Technical Guidelines for Clinical Single- And Multiple-...

12/29/202118 Promising Novel Drugs Expected to Be Approved in China 2022

12/29/2021Top Ten Chinese Biopharma In-licensing Deals in 2021

12/28/2021SMEI Forecasts Outlook of Chinese Pharma in 2022

12/27/2021NMPA Announces Rx Switch of OTC Dextromethorphan Hydrobromide Oral Sin...

12/27/2021ITM and Grand Pharma Enter Licensing Deal for Targeted Radiopharmaceut...

12/27/2021Kintor Reports Unsatisfactory Interim Analysis on COVID-19 Pill Trial

12/27/2021China's 2021 Negative Lists Widen Market Access for Foreign Investment...

12/24/2021Cosunter Pharma Partners with WuXi AppTec to Co-develop New Covid Dru...

12/23/2021Luye Grants Genscience Chinese Commercialization Rights of Rivastigmin...

12/23/2021TOT Enters Co-promotion Deal with Jiangxi Jimin Kexin for Its Bevaciz...

12/23/2021Sanofi Secures Additional Indication for Multaq (Dronedarone) in China

12/23/2021Pfizer Gains Chinese Approval of ADC Drug Besponsa

12/21/2021CDE Seeks Comments on Draft Chinese Translation of ICH Guideline ICH M...

12/21/2021CStone announced New Drug Approval of Cejemly® (Sugemalimab) in China

12/21/2021Pfizer Wins Chinese BLA Approval of Inotuzumab Ozogamicin for BCP-ALL

12/20/2021NHSA Issues the List of DRG/DIP Reform Demo Trial Sites

12/20/2021NHC Issues the Guidelines for Building and Management of Pharmacy Intr...

12/20/2021Novartis and BeiGene Expands Collaboration to BeiGene's TIGIT Inhibito...

Page:51/333 Total number of articles:9989: [First][<<] [49] [50] [51] [52] [53] [>>] [End]